scholarly article | Q13442814 |
P356 | DOI | 10.1016/J.ANTIVIRAL.2011.05.009 |
P698 | PubMed publication ID | 21641936 |
P50 | author | Susanne Herold | Q51023448 |
Stephan Pleschka | Q123614404 | ||
P2093 | author name string | Jürgen Lohmeyer | |
Oliver Planz | |||
Lidija Cakarova | |||
Katrin Hoegner | |||
Ruth Pinto | |||
P433 | issue | 1 | |
P921 | main subject | NF-κB | Q411114 |
P304 | page(s) | 45-56 | |
P577 | publication date | 2011-05-27 | |
P1433 | published in | Antiviral Research | Q4775352 |
P1476 | title | Inhibition of influenza virus-induced NF-kappaB and Raf/MEK/ERK activation can reduce both virus titers and cytokine expression simultaneously in vitro and in vivo | |
P478 | volume | 92 |
Q45341960 | 2-Pyridinyl-4(3H)-quinazolinone: a scaffold for anti-influenza A virus compounds. |
Q52595634 | Bat lung epithelial cells show greater host species-specific innate resistance than MDCK cells to human and avian influenza viruses. |
Q36255049 | Carnosine markedly ameliorates H9N2 swine influenza virus-induced acute lung injury |
Q38051178 | Cytokine responses in the common cold and otitis media |
Q89967193 | Discovery of Multitarget-Directed Ligands Against Influenza A Virus From Compound Yizhihao Through a Predictive System for Compound-Protein Interactions |
Q39229980 | EP4 Receptor-Associated Protein in Macrophages Protects against Bleomycin-Induced Pulmonary Inflammation in Mice. |
Q34104767 | Early activation of MAP kinases by influenza A virus X-31 in murine macrophage cell lines |
Q35193700 | Effects of flavonoid-induced oxidative stress on anti-H5N1 influenza a virus activity exerted by baicalein and biochanin A. |
Q37117819 | Efficient influenza A virus replication in the respiratory tract requires signals from TLR7 and RIG-I. |
Q94563280 | Erucic acid from Isatis indigotica Fort. suppresses influenza A virus replication and inflammation in vitro and in vivo through modulation of NF-κB and p38 MAPK pathway |
Q41450597 | FPR2: A Novel Promising Target for the Treatment of Influenza |
Q107272360 | Genome-wide, bidirectional CRISPR screens identify mucins as critical host factors modulating SARS-CoV-2 infection |
Q38007145 | Highlights in antiviral drug research: antivirals at the horizon |
Q34785589 | Identification of Host Kinase Genes Required for Influenza Virus Replication and the Regulatory Role of MicroRNAs. |
Q28541723 | In vitro anti-influenza virus activities of a new lignan glycoside from the latex of Calotropis gigantea |
Q30353167 | Influenza A induced cellular signal transduction pathways. |
Q39297691 | Influenza A virus-encoded NS1 virulence factor protein inhibits innate immune response by targeting IKK. |
Q92213134 | Inhibition effects of patchouli alcohol against influenza a virus through targeting cellular PI3K/Akt and ERK/MAPK signaling pathways |
Q37547432 | Inhibition of NF-κB-mediated inflammation in severe acute respiratory syndrome coronavirus-infected mice increases survival |
Q33612279 | Innate immune response to a H3N2 subtype swine influenza virus in newborn porcine trachea cells, alveolar macrophages, and precision-cut lung slices. |
Q92571985 | Morusin alleviates mycoplasma pneumonia via the inhibition of Wnt/β-catenin and NF-κB signaling |
Q41196865 | Mouse lung slices: An ex vivo model for the evaluation of antiviral and anti-inflammatory agents against influenza viruses |
Q34413797 | New treatments for influenza |
Q58745484 | Newcastle Disease Virus V Protein Promotes Viral Replication in HeLa Cells through the Activation of MEK/ERK Signaling |
Q38382900 | Pathophysiology of Clinical Symptoms in Acute Viral Respiratory Tract Infections. |
Q45326286 | Pterodontic Acid Isolated from Laggera pterodonta Inhibits Viral Replication and Inflammation Induced by Influenza A Virus |
Q56967921 | Redox Biology of Respiratory Viral Infections |
Q94547260 | Sinensetin suppresses influenza a virus-triggered inflammation through inhibition of NF-κB and MAPKs signalings |
Q37014063 | Sprouty-Related Ena/Vasodilator-Stimulated Phosphoprotein Homology 1-Domain-Containing Protein-2 Critically Regulates Influenza A Virus-Induced Pneumonia |
Q24632337 | Structure-based discovery of the novel antiviral properties of naproxen against the nucleoprotein of influenza A virus |
Q52671141 | Targeting intracellular signaling as an antiviral strategy: aerosolized LASAG for the treatment of influenza in hospitalized patients. |
Q38047645 | Targeting the host or the virus: current and novel concepts for antiviral approaches against influenza virus infection |
Q36290432 | The Chinese prescription lianhuaqingwen capsule exerts anti-influenza activity through the inhibition of viral propagation and impacts immune function |
Q28071809 | The Influenza Virus Polymerase Complex: An Update on Its Structure, Functions, and Significance for Antiviral Drug Design |
Q110566468 | The MEK1/2-inhibitor ATR-002 efficiently blocks SARS-CoV-2 propagation and alleviates pro-inflammatory cytokine/chemokine responses |
Q46853154 | The intricate interplay between RNA viruses and NF-κB. |
Q38482440 | Transcriptome profiling of brain edemas caused by influenza infection and lipopolysaccharide treatment |
Q42229719 | Transfection of influenza A virus nuclear export protein induces the expression of tumor necrosis factor alpha. |
Q40225256 | Transmissible gastroenteritis virus infection induces NF-κB activation through RLR-mediated signaling |
Q96172107 | β-sitosterol ameliorates influenza A virus-induced proinflammatory response and acute lung injury in mice by disrupting the cross-talk between RIG-I and IFN/STAT signaling |
Search more.